Dynavax Technologies | search
Click here to view Dynavax Technologies news from 60+ newspapers.
Bookmark or Share- Dynavax Highlights 2022 Priorities and Announces Initiation of Phase 1 ...Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines,... Dynavax to Present at TD Cowen's 44th...
- Investor Relations | Dynavax Technologies CorporationDynavax is a commercial-stage biopharmaceutical company built on the foundation of our significant experience and expertise in vaccine development and commercialization. Our mission is to develop and commercialize novel vaccines to help protect the world against infectious diseases.
- Dynavax Technologies | Toll-like Receptor | VaccinesWe are a commercial-stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases, by utilizing proven, innovative adjuvant technology.
- Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and ...Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines,... Dynavax to Present at TD Cowen's 44th Annual ...
- Dynavax Technologies Corporation (DVAX) - Yahoo FinanceFind the latest Dynavax Technologies Corporation (DVAX) stock quote, history, news and other vital information to help you with your stock trading and investing.
More
